Halozyme Therapeutics, Inc.Equity-NMS: HALO
Equity-NMS: HALO
$36
-0.10
(20 Feb)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$36.00
Open
$36.00
Today’s high
$36.27
Today’s low
$35.50
52W low
$29.85
52W high
$51.45
1Y
-27.85%
5Y
16.36%
PE
18.78
EPS (TTM)
1.86
Shares O/S
132.10M
Market cap
4.76B
Insights
No insights found for this stock
Compare with other stock
Price
1D
PE
Market cap
About Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. is a biopharma technology platform company. The Company licenses its technology to biopharmaceutical companies to collaboratively develop products that combine its ENHANZE drug delivery technology with the collaborators' compounds. The Company’s proprietary enzyme, rHuPH20, is used to facilitate the subcutaneous (SC) delivery of injected drugs and fluids.

The Company’s commercially approved product, Hylenex recombinant (Hylenex), and its ENHANZE partners approved products and product candidates are based on rHuPH20. It also develops, manufactures, and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technology that is designed to provide commercial or functional advantages. It has a commercial portfolio of proprietary products, including XYOSTED, TLANDO and NOCDURNA and partnered commercial products and ongoing product development programs with several pharmaceutical companies. .


FAQs

Can I buy Halozyme Therapeutics, Inc. shares in India?
How to buy Halozyme Therapeutics, Inc. shares in India?
What is the share price of Halozyme Therapeutics, Inc.?
What is the Market Capitalization of Halozyme Therapeutics, Inc.?
What is the PE ratio of Halozyme Therapeutics, Inc.?
Is Halozyme Therapeutics, Inc. a good stock to buy?
In which sector / industry does Halozyme Therapeutics, Inc. operate?